Electroconvulsive Therapy, Manufacturers’ Liability, and Learned Intermediaries

Manufacturers of drugs or devices that are prescribed by physicians are protected by the "learned intermediary rule" from having to disclose risks directly to patients. Instead, they must inform physicians of these risks. But when a company fails to disclose a known risk, how can a patient gain compensation for any resulting harm? The California Supreme Court considered this question in a case involving alleged memory impairment from electroconvulsive therapy. By broadening the ways by which plaintiffs can demonstrate that the absence of a warning caused their injury, the court made it easier for patients to recover compensation for the consequences.

Authors

Institutions

Publication Details

Journal
Psychiatric Services
Published
2024-11-19
DOI
https://doi.org/10.1176/appi.ps.20240518
Citations
3
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Electroconvulsive Therapy, Manufacturers’ Liability, and Learned Intermediaries

Paul S. Appelbaum
3 citations
Psychiatric Services
Pharmaceutical industry and healthcare
1.40
article

Electroconvulsive Therapy, Manufacturers’ Liability, and Learned Intermediaries

Paul S. Appelbaum
article en
3 citations

Abstract

Manufacturers of drugs or devices that are prescribed by physicians are protected by the "learned intermediary rule" from having to disclose risks directly to patients. Instead, they must inform physicians of these risks. But when a company fails to disclose a known risk, how can a patient gain compensation for any resulting harm? The California Supreme Court considered this question in a case involving alleged memory impairment from electroconvulsive therapy. By broadening the ways by which plaintiffs can demonstrate that the absence of a warning caused their injury, the court made it easier for patients to recover compensation for the consequences.

Psychiatric ServicesVol. 76(1)
Columbia University (US)
Openalex Percentile: Top 18%
Pharmaceutical industry and healthcare
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.